rs621554 single nucleotide polymorphism of DLC1 is associated with breast cancer susceptibility and prognosis

Ding,Xia; Gao,Sumei; Yang,Qifeng

doi:10.3892/mmr.2016.4987

rs621554 single nucleotide polymorphism of DLC1 is associated with breast cancer susceptibility and prognosis

Authors:
- Xia Ding
- Sumei Gao
- Qifeng Yang
View Affiliations

Affiliations: Department of Oncology, Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China, Department of Breast Surgery, Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China
Published online on: March 8, 2016 https://doi.org/10.3892/mmr.2016.4987
Pages: 4095-4100

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Deleted in liver cancer 1 (DLC1) on chromosome 8p22, is an important tumor suppressor gene originally identified to be deleted in hepatocellular carcinoma. It can regulate the structure of the actin cytoskeleton and inhibit cell proliferation, motility and angiogenesis, which predominantly depends on its homology to rat RhoGAP. There are many genetic variants in DLC1, which may influence its antitumor efficacy. The rs621554 (IVS19+108C>T) polymorphism is a synonymous single nucleotide polymorphism (SNP) previously found to be associated with hepatocellular carcinoma. In the present study, 453 patients with breast cancer and 330 healthy females were analyzed using a cycling probe method. It was determined that the rs621554 polymorphism of DLC1 was associated with breast cancer susceptibility, with the CC and CT genotypes resulting in a higher risk of developing breast cancer. In regard to clinicopathological variables, it was demonstrated that the CT and CC genotype were associated with tumor size, lymph node metastasis and progesterone receptor status. Patients with the CT and CC genotype had shorter disease-free survival and overall survival rates compared with those with the TT genotype. Additionally, it was demonstrated that the rs621554 polymorphism was correlated with DLC1 expression at the mRNA level. These results suggested that the rs621554 polymorphism is associated with breast cancer susceptibility and prognosis, and may serve as a biomarker for breast cancer development and progression.

View Figures

View References

1	Basu S, Nachat-Kappes R, Caldefie-Chézet F and Vasson MP: Eicosanoids and adipokines in breast cancer: from molecular mechanisms to clinical considerations. Antioxid Redox Signal. 18:323–360. 2013. View Article : Google Scholar
2	Bray F, Jemal A, Grey N, Ferlay J and Forman D: Global cancer transitions according to the Human Development Index (2008–2030): a population-based study. Lancet Oncol. 13:790–801. 2012. View Article : Google Scholar : PubMed/NCBI
3	Børresen AL: Role of genetic factors in breast cancer susceptibility. Acta Oncol. 31:151–155. 1992. View Article : Google Scholar : PubMed/NCBI
4	Bishop DT: The involvement of genetic factors in susceptibility to breast cancer. Eur J Cancer Prev. 2(Suppl 3): 125–130. 1993. View Article : Google Scholar : PubMed/NCBI
5	Mavaddat N, Antoniou AC, Easton DF and Garcia-Closas M: Genetic susceptibility to breast cancer. Molr Oncol. 4:174–191. 2010. View Article : Google Scholar
6	Nickels S, Truong T, Hein R, et al: Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet. 9:e10032842013. View Article : Google Scholar : PubMed/NCBI
7	Czerska K, Nawara M and Bal J: I. Single nucleotide polymorphism in human genetic analyses. Med Wieku Rozwoj. 7:531–546. 2003.In Polish.
8	Erichsen HC and Chanock SJ: SNPs in cancer research and treatment. Br J Cancer. 90:747–751. 2004. View Article : Google Scholar : PubMed/NCBI
9	Zhang N, Li X, Tao K, et al: BCL-2 (-938C > A) polymorphism is associated with breast cancer susceptibility. BMC Med Genet. 12:482011. View Article : Google Scholar :
10	Romanowicz-Makowska H, Bryś M, Forma E, et al: Single nucleotide polymorphism (SNP) Thr241Met in the XRCC3 gene and breast cancer risk in Polish women. Pol J Pathol. 63:121–125. 2012.PubMed/NCBI
11	Popescu NC and Goodison S: Deleted in liver cancer-1 (DLC1): an emerging metastasis suppressor gene. Mol Diagn Ther. 18:293–302. 2014. View Article : Google Scholar : PubMed/NCBI
12	Yamaga M, Kawai K, Kiyota M, Homma Y and Yagisawa H: Recruitment and activation of phospholipase C (PLC)-delta1 in lipid rafts by muscarinic stimulation of PC12 cells: contribution of p122RhoGAP/DLC1, a tumor-suppressing PLCdelta1 binding protein. Adv Enzyme Regul. 48:41–54. 2008. View Article : Google Scholar
13	Shih YP, Liao YC, Lin Y and Lo SH: DLC1 negatively regulates angiogenesis in a paracrine fashion. Cancer Res. 70:8270–8275. 2010. View Article : Google Scholar : PubMed/NCBI
14	Zhou X, Thorgeirsson SS and Popescu NC: Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells. Oncogene. 23:1308–1313. 2004. View Article : Google Scholar
15	Zheng SL, Mychaleckyj JC, Hawkins GA, et al: Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association study. Mutat Res. 528:45–53. 2003. View Article : Google Scholar : PubMed/NCBI
16	Dong X, Zhou G, Zhai Y, et al: Association of DLC1 gene polymorphism with susceptibility to hepatocellular carcinoma in Chinese hepatitis B virus carriers. Cancer Epidemiology. 33:265–270. 2009. View Article : Google Scholar : PubMed/NCBI
17	Suzuki Y, Saito R, Zaraket H, Dapat C, Caperig-Dapat I and Suzuki H: Rapid and specific detection of amantadine-resistant influenza A viruses with a Ser31Asn mutation by the cycling probe method. J Clin Microbiol. 48:57–63. 2010. View Article : Google Scholar :
18	Temin HM: Evolution of cancer genes as a mutation-driven process. Cancer Res. 48:1697–1701. 1988.PubMed/NCBI
19	Zheng W, Long J, Gao YT, et al: Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet. 41:324–328. 2009. View Article : Google Scholar : PubMed/NCBI
20	Yuan BZ, Miller MJ, Keck CL, Zimonjic DB, Thorgeirsson SS and Popescu NC: Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res. 58:2196–2199. 1998.PubMed/NCBI
21	Zhou X, Zimonjic DB, Park SW, Yang XY, Durkin ME and Popescu NC: DLC1 suppresses distant dissemination of human hepatocellular carcinoma cells in nude mice through reduction of RhoA GTPase activity, actin cytoskeletal disruption and down-regulation of genes involved in metastasis. Int J Oncol. 32:1285–1291. 2008.PubMed/NCBI
22	Ullmannova V and Popescu NC: Expression profile of the tumor suppressor genes DLC-1 and DLC-2 in solid tumors. Int J Oncol. 29:1127–1132. 2006.PubMed/NCBI
23	Xie CR, Sun HG, Sun Y, et al: Significance of genetic variants in DLC1 and their association with hepatocellular carcinoma. Mol Med Rep. 12:4203–4209. 2015.PubMed/NCBI
24	Dai X, Li L, Liu X, Hu W, Yang Y and Bai Z: Cooperation of DLC1 and CDK6 affects breast cancer clinical outcome. G3 (Bethesda). 5:81–91. 2014.
25	Lee PH and Shatkay H: F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic Acids Res. 36:D820–D824. 2008. View Article : Google Scholar :